Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
Globe Newswire•18/09/2026•07:30 ET
0
Get started
Create a free account to read the full story and Whiz Insights.
Create a free account to read the full story and Whiz Insights.